NIH Grants Focus on Priority Illnesses, Diabetes

Nat'l Institutes of Health logoAgency: National Institutes of Health (HHS); Program: Addressing Health Disparities in National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Diseases (CFDA Number: 93.847) (Funding Opportunity Number: PA-17-021); Eligibility: State, tribal and local governments, public and private universities, public housing authorities, nonprofits and for-profits; Funding: Multiple awards (no match required); Deadline: Feb. 5.

Summary: The program supports research to improve understanding of the causes of high priority NIDDK diseases in the United States and reducing and eliminating health disparities. Research is encouraged in the following high priority diseases: diabetes; obesity; nutrition-related disorders; hepatitis C; gallbladder disease; sickle cell disease; kidney diseases; urologic diseases; hematologic diseases; metabolic diseases; gastrointestinal, hepatic, and renal complications from infection with HIV.

Info: https://goo.gl/WZohoc (NOFA): for questions, e-mail, GrantsInfo@nih.gov; or telephone, 301/710-0267.

About Frank Klimko

Frank Klimko is a nationally known journalist, grants expert and speech writer/speaker. He has years of experience helping nonprofits devise lists of the right funding opportunities and secure funding from these foundations and corporate entities. Clients have focused on an array of areas including child care, homeless, hunger and K-12 education. Additionally, he is a Freedom of Information Act expert, who has helped numerous clients with securing proprietary information from the federal government. Currently, Frank Klimko writes the Children & Youth Funding Report and Private Grants Alert, which are Washington DC-based publications. CYF is a daily publication covering Congress, the Education Dept. and the various federal regulatory agencies. PGA, another daily publication, covers the world of private philanthropy.
This entry was posted in Federal Funding and tagged , . Bookmark the permalink.